p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival.
about
Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancerGenomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast CancerCell cycle related proteins in hyperplasia of usual type in breast specimens of patients with and without breast cancer.A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.Prognostic and predictive value of p53 and p21 in breast cancer.Cell cycle regulators and their abnormalities in breast cancer.Expression of the cell cycle regulatory proteins p34cdc2, p21waf1, and p53 in node negative invasive ductal breast carcinoma.Patterns of p21(waf1/cip1) expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomasp21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.p53 mutations and expression in breast carcinoma in situ.Prognostic significance of cyclin E and p53 protein overexpression in carcinoma of the renal pelvis and ureterAbsence of p21 expression is associated with abnormal p53 in human breast carcinomas.Expression of molecular biomarkers in primary breast tumors implanted into a surrogate host: increased levels of cyclins correlate with tumor progressionThe molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous systemDifferential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoringp21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression.Differentiation and cancer in the mammary gland: shedding light on an old dichotomy.Immunohistochemical expression of Bcl-2, Ki-67, and p21 in patients with papillary thyroid cancer.The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.p21(WAF1) expression and endocrine response in breast cancer.Apoptosis and its relationship with cell proliferation, p53, Waf1p21, bcl-2 and c-myc in esophageal carcinogenesis studied with a high-risk population in northern China.Cyclin D1 overexpression in a model of human breast premalignancy: preferential stimulation of anchorage-independent but not anchorage-dependent growth is associated with increased cdk2 activity.Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1.Anticancer activity of marine sponge Hyrtios sp. extract in human colorectal carcinoma RKO cells with different p53 status.Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma.EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast.Cyclin-dependent kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer.The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.Cell cycle control related proteins (p53, p21, and Rb) and transforming growth factor beta (TGFbeta) in benign and carcinomatous (in situ and infiltrating) human breast: implications in malignant transformations.The Cell Cycle: A ReviewMolecular pathology parameters in human nasopharyngeal carcinoma
P2860
Q24803723-BA279062-8BED-4D7A-BB24-24DDA18EABB6Q26738987-30A237B6-D01B-4583-9556-716BFD127DA4Q30820696-C818888C-20EA-44C1-A765-381CD262FD0EQ33483295-FB61994C-D35D-488A-8C22-4CB939E5EAA6Q33538430-D7E495B7-004F-46DB-82F5-A13B14863DEDQ33588357-AC267B23-84B2-406E-8951-8A22D9208F02Q33919277-2C4C9680-0BB9-4AB9-876C-8B18085402B2Q35397887-1998FFC4-5355-4AB7-88C5-56A6BB5DCE26Q35586711-14EAB2C9-E504-4C93-B09E-AFF339A67F87Q35793421-99497E58-8608-4894-A78E-7E2B436A6E06Q36291799-A3DF4B55-0EE7-453B-A660-A88AB4DB9527Q36430949-9C3D33F7-9478-4C88-B460-A8B79D8CE523Q36437747-3A4647AD-3C72-47B7-9D91-F0DB1FD7C2F6Q36623905-B3DF9D10-EEF3-4DD0-8144-B2B2FD2AD397Q36643624-DDB1D203-F8CC-4A89-B3DA-4BFD42FC58A3Q37217826-14E3D15A-C0F5-4B36-A370-9BFDF172D5A5Q37401876-AD679FD4-70DD-411F-93B4-A1BD280D9906Q38443584-A3AF9CC9-70BB-4E4E-8B5F-D96D6562CDF1Q38447618-02348823-7BE1-4F4B-8E2A-E5100D343797Q38468028-24B84D96-C77E-465C-A27B-4C73D17DD198Q38577946-1ADC9462-E5D4-4A47-A5A2-A361934D4541Q40888652-D84242AD-D377-4245-80E5-23BBF68D8CE2Q41656068-CC72B84A-B6BD-45DC-8F9E-72C1FCC498CDQ42180939-47B3C5F3-7095-4D26-B7E2-286D29C45B52Q43572717-F142B40D-E356-433A-B3F5-9C83E02A2C08Q44490794-06C4A9C6-F96E-46A7-ACBD-AEE6C96090B0Q45164090-B80C63B2-8B8F-4EA5-858A-90265B75D28FQ52923628-0D5ED520-C988-40A3-9673-AC29D560C038Q53348407-7E80678E-173B-4751-9B76-EE8D4C021CBDQ57405732-E8E36067-673D-4C67-996F-8A2EB26453E8Q58876777-59D1A25B-D60E-48D3-A451-92A069A42346
P2860
p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
p21WAF1 immunohistochemical ex ...... ons and relapse-free survival.
@ast
p21WAF1 immunohistochemical ex ...... ons and relapse-free survival.
@en
type
label
p21WAF1 immunohistochemical ex ...... ons and relapse-free survival.
@ast
p21WAF1 immunohistochemical ex ...... ons and relapse-free survival.
@en
prefLabel
p21WAF1 immunohistochemical ex ...... ons and relapse-free survival.
@ast
p21WAF1 immunohistochemical ex ...... ons and relapse-free survival.
@en
P2093
P2860
P356
P1476
p21WAF1 immunohistochemical ex ...... ons and relapse-free survival.
@en
P2093
Barbareschi M
Bevilacqua G
Buttitta F
Dalla Palma P
Doglioni C
Leonardi E
P2860
P2888
P304
P356
10.1038/BJC.1996.339
P407
P577
1996-07-01T00:00:00Z